Company profile
BillionToOne, Inc.
NASDAQ: BLLN · Healthcare · Medical - Diagnostics & Research
#247 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
53DFH 84DQ 6GM —SS 59
v0.1 · 55/100 weight · provisional
↑ Piotroski F, Altman-Z · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$397.4M
Rev growth YoY (TTM)
+90.1%
Net income (FY)
$7.5M
Employees
713
as of 2026-08-07
Market cap
$4.2B
as of 2026-08-07
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$305.1M$305.1M2025
Net income$7.5M$7.5M2025
Operating income$16.0M$16.0M2025
Total assets$632.7M$632.7M2025
Liabilities$152.5M$152.5M2025
Equity$480.1M$480.1M2025
Revenue trend
FY2025 – FY2025 · USD
FY25
FY25
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is BillionToOne, Inc.’s revenue?
BillionToOne, Inc. booked $305.1M in FY2025 revenue, growing 100% year over year — faster than most Healthcare companies we track, at a 2.4% net margin.
Peers · Healthcare
CorMedix Inc.75B+Health Catalyst, Inc.56CPROCEPT BioRobotics Corporation63CHealthStream, Inc.82B+The Beauty Health Company57CEvolus, Inc.59CNeighbors
San Mateo →Key facts
CEOOguzhan Atay
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersMenlo Park, CA
ExchangeNASDAQ: BLLN
Employees713
IPO date2025-11-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.